John S. Wold
Impact in
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 15
- Antibiotics Pharmacokinetics and Efficacy 14
- Pharmacogenetics and Drug Metabolism 5
-
- Phenothiazines and Benzothiazines Synthesis and Activities 3
- Co-authors
- Luana Fischer (2 shared papers)Mildred K. Buening (2 shared papers)Daniel S. Longnecker (2 shared papers)L.J. Fischer (2 shared papers)Lawrence J. Fischer (1 shared paper)William J. Steele (1 shared paper)Douglas E. Rickert (1 shared paper)Douglas M. Morton (2 shared papers)
- Journals
- Clinical Infectious Diseases (4 papers)Toxicology and Applied Pharmacology (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Drug Metabolism and Disposition (2 papers)
- Partner nations
- United StatesJapanCanada
In The Last Decade
John S. Wold
24 papers receiving 396 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 227
- Molecular Medicine 35
- Pharmacology 55
- Clinical Biochemistry 36
- Analytical Chemistry 45
Countries citing papers authored by John S. Wold
This map shows the geographic impact of John S. Wold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Wold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Wold more than expected).
Fields of papers citing papers by John S. Wold
This network shows the impact of papers produced by John S. Wold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Wold. The network helps show where John S. Wold may publish in the future.
Co-authors
The 17 scholars most cited alongside John S. Wold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1981 | 71 | |
| 2 | 1977 | 33 | |
| 3 | 1977 | 33 | |
| 4 | 1975 | 30 | |
| 5 | 1977 | 29 | |
| 6 | 1979 | 26 | |
| 7 | 1971 | 24 | |
| 8 | 1982 | 24 | |
| 9 | 1972 | 23 | |
| 10 | 1981 | 23 | |
| 11 | 1972 | 21 | |
| 12 | 1977 | 16 | |
| 13 | 1983 | 16 | |
| 14 | 1980 | 13 | |
| 15 | 1978 | 12 | |
| 16 | 1973 | 11 | |
| 17 | 1978 | 10 | |
| 18 | 1978 | 8 | |
| 19 | 1972 | 7 | |
| 20 | 1977 | 6 |
About John S. Wold
John S. Wold is a scholar working on Pharmacology, Molecular Biology, Pediatrics, Perinatology and Child Health, Pharmacology and Molecular Medicine, having authored 24 papers that have together received 448 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Antibiotic Resistance in Bacteria (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Metabolism and Genetic Disorders (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Pancreatic function and diabetes (3 papers). The work is most often cited by research in Pharmacology (227 citations), Molecular Medicine (35 citations), Pharmacology (55 citations), Clinical Biochemistry (36 citations) and Analytical Chemistry (45 citations). John S. Wold has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Luana Fischer, Mildred K. Buening, Daniel S. Longnecker, L.J. Fischer, Lawrence J. Fischer, William J. Steele, Douglas E. Rickert, Douglas M. Morton, J. R. Turner and David A. Preston. Their work appears in journals such as Clinical Infectious Diseases, Toxicology and Applied Pharmacology, Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.